Already on semaglutide or tirzepatide? Here’s what your GLP-1 can and can’t do for women in perimenopause and menopause.
If you’re a woman in your 40s or 50s and you’ve started a GLP-1 medication like semaglutide or tirzepatide, you may have noticed something surprising: the number on the scale is moving but you still don’t feel quite like yourself. The brain fog is still there. You’re waking at 3 a.m. drenched in sweat. Your joints ache. Your energy is flat.
You’re not doing anything wrong. It’s just that your GLP-1, as effective as it is, wasn’t designed to fix your hormones.
Your GLP-1, as effective as it is, wasn’t designed to fix your hormones.
How GLP-1 Medications Work
GLP-1 receptor agonists mimic a natural gut hormone called glucagon-like peptide-1, which helps regulate appetite, blood sugar, and digestion. For midlife women, they can significantly reduce hunger and support substantial, sustained weight loss when combined with lifestyle changes.
Specifically, GLP-1s work by:
- Slowing gastric emptying so you feel full longer
- Acting on appetite centers in the brain to reduce cravings
- Increasing insulin secretion and reducing glucagon to improve blood sugar control
The clinical trial results speak for themselves. The STEP 1 trial showed semaglutide 2.4 mg produced an average 14.9% body weight reduction at 68 weeks.¹ Tirzepatide (SURMOUNT-1) showed up to 20.9% mean weight loss at 72 weeks.² These are meaningful results — especially for women in menopause who often gain 3–5 pounds per year due to hormonal shifts.
Average body weight reduction at 68 weeks with Semaglutide 2.4 mg¹
Mean weight loss at 72 weeks with Tirzepatide (SURMOUNT-1)²
Why GLP-1 Alone May Not Be Enough in Perimenopause and Menopause
Even with impressive weight loss, GLP-1s do not directly treat:
- Hot flashes and night sweats
- Sleep disruption from hormonal changes
- Mood swings, anxiety, and brain fog
- Vaginal dryness, painful sex, or low libido
- Bone loss and long-term osteoporosis risk
That’s the hormonal story and it’s a big one. Many women in midlife are losing weight but still feeling exhausted, foggy, or emotionally flat. These symptoms have a different root cause: declining estrogen, progesterone, and sometimes testosterone.
GLP-1s optimize your hunger and satiety signals. But they don’t touch the internal hormonal environment your brain, bones, and mood depend on. That’s where HRT( Hormone Replacement Therapy) enters the picture.
What’s Next
If your GLP-1 is working but you still don’t feel like yourself, it may be worth asking whether your hormones are part of the story. A menopause-trained clinician can help you evaluate your symptoms, discuss your options, and design a plan tailored to where you are in the transition.
Disclaimer: This article is for educational purposes only and does not replace medical advice. Always speak with a qualified healthcare provider before starting, stopping, or combining any medications including HRT and GLP-1 therapies. Individual results vary. No specific outcome is guaranteed.
References:
- STEP 1 Trial – Semaglutide 2.4 mg for weight management.
- SURMOUNT-1 Trial – Tirzepatide for obesity.



